Striae Clinical Trial - 755nm Alex Laser for Treatment of Stretch Marks

See also
Status	Clinical Trial	Phase
Completed	`NCT01027793` - Trial Comparing Treatment of Tretinoin or Superficial Dermabrasion for Stretch Marks	Phase 4
Completed	`NCT01810484` - Feasibility Study: Evaluation of the Treatment of Striae Using Ultherapy® in Combination With Laser Treatment	N/A
Completed	`NCT01788748` - Evaluation of Fractional Bipolar Radiofrequency for the Treatment of Striae	N/A
Completed	`NCT01796626` - Clinical Evaluation of M22 ResurFX 1565nm Module	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT01027793 - Trial Comparing Treatment of Tretinoin or Superficial Dermabrasion for Stretch Marks

Phase 4

Completed

NCT01810484 - Feasibility Study: Evaluation of the Treatment of Striae Using Ultherapy® in Combination With Laser Treatment

N/A

Completed

NCT01788748 - Evaluation of Fractional Bipolar Radiofrequency for the Treatment of Striae

N/A

Completed

NCT01796626 - Clinical Evaluation of M22 ResurFX 1565nm Module

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT01745211
Study type	Interventional
Source	Cynosure, Inc.
Contact
Status	Completed
Phase	N/A
Start date	January 2012
Completion date	November 2013

755nm Alex Laser for Treatment of Stretch Marks

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms